Meng et al. used a knockout mouse model of TGF-β receptor 2 (TGFBR2) in osteoblasts and a knockout mouse model of TGFBR2 in osteoclasts to determine the effects of TGF-β signaling in prostate cancer bone metastases [148]. The gene discussed is TGFBR2; the disease is prostate carcinoma.